Back
American Vanguard 10K Form
Sell
27
AVD
American Vanguard
Last Price:
$4.13
Seasonality Move:
-2.92%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-09 | 10Q | AVD/American Vanguard Quarterly |
2023-11-09 | 10Q | AVD/American Vanguard Quarterly |
2023-08-09 | 10Q | AVD/American Vanguard Quarterly |
2023-05-10 | 10Q | AVD/American Vanguard Quarterly |
2022-11-08 | 10Q | AVD/American Vanguard Quarterly |
2022-08-08 | 10Q | AVD/American Vanguard Quarterly |
Receive AVD News And Ratings
See the #1 stock for the next 7 days that we like better than AVD
AVD Financial Statistics
Sales & Book Value
Annual Sales: | $547.3M |
---|---|
Cash Flow: | $-21M |
Price / Cash Flow: | 7.85 |
Annual Sales: | $7.86 |
Price / Book: | 0.52 |
Profitability
EPS (TTM): | -4.85000 |
---|---|
Net Income (TTM): | $-136.4M |
Gross Margin: | $120.3M |
Return on Equity: | -45.06% |
Return on Assets: | -18.85% |
American Vanguard Earnings Forecast
Key American Vanguard Financial Ratios
-
The Gross Profit Margin over the past 39 years for AVD is 21.98%.
-
The Selling, General & Administrative Expenses for AVD have been equal to 21.86% of Gross Profit Margin.
-
The Research & Development expenses have been 5.97% of Revenue.
-
The Net Earning history of AVD is -23.08% of Total Revenues.
-
Per Share Earnings over the last 39 years have been positive in 25 years.
American Vanguard Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Chemicals |
Sector: | Materials |
Current Symbol: | AVD |
CUSIP: | 030371 |
Website: | american-vanguard.com |
Debt
Debt-to-Equity Ratio: | 0.74 |
---|---|
Current Ratio: | 1.77 |
Quick Ratio: | 0.87 |
Price-to-Earnings
Trailing P/E Ratio: | 17.04 |
---|---|
Forward P/E Ratio: | 0 |
AVD Technical Analysis vs Fundamental Analysis
Sell
27
American Vanguard (AVD)
is a Sell
Is American Vanguard a Buy or a Sell?
-
American Vanguard stock is rated a SellThe current American Vanguard [AVD] share price is $4.15. The Score for AVD is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.